MPS Pharmaa Limited (BOM:531686)
India
· Delayed Price · Currency is INR 1.650
0.00 (0.00%)
At close: Mar 9, 2026
MPS Pharmaa Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | - | - | - | 0.32 | - | Upgrade
|
| Other Revenue | 0 | 0.48 | 0.94 | 0.23 | 0 | - | Upgrade
|
| Revenue | 0 | 0.48 | 0.94 | 0.23 | 0.33 | - | Upgrade
|
| Revenue Growth (YoY) | -99.96% | -49.05% | 302.00% | -28.85% | - | - | Upgrade
|
| Cost of Revenue | 0.18 | 0.18 | 0.28 | 2.09 | 0.61 | 0.07 | Upgrade
|
| Gross Profit | -0.18 | 0.3 | 0.66 | -1.86 | -0.28 | -0.07 | Upgrade
|
| Selling, General & Admin | 5.3 | 5.29 | 5.32 | 4.96 | 4.26 | 4.07 | Upgrade
|
| Other Operating Expenses | 2.21 | 2.17 | 2.39 | 2.43 | 2.19 | 37.16 | Upgrade
|
| Operating Expenses | 8.98 | 8.92 | 9.17 | 8.84 | 11.59 | 46.79 | Upgrade
|
| Operating Income | -9.16 | -8.63 | -8.51 | -10.7 | -11.86 | -46.86 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.04 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | -0.01 | -0.01 | -0.01 | 0.16 | Upgrade
|
| EBT Excluding Unusual Items | -9.18 | -8.64 | -8.53 | -10.71 | -11.86 | -46.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 | Upgrade
|
| Other Unusual Items | - | - | - | - | 2.54 | - | Upgrade
|
| Pretax Income | -9.18 | -8.64 | -8.53 | -10.71 | -9.32 | -44.94 | Upgrade
|
| Income Tax Expense | 0.23 | 0.34 | -0.22 | -0.21 | -7.91 | -0.78 | Upgrade
|
| Net Income | -9.4 | -8.98 | -8.31 | -10.5 | -1.42 | -44.17 | Upgrade
|
| Net Income to Common | -9.4 | -8.98 | -8.31 | -10.5 | -1.42 | -44.17 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 19 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 19 | 19 | Upgrade
|
| Shares Change (YoY) | -3.21% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.50 | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 | Upgrade
|
| EPS (Diluted) | -0.50 | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 | Upgrade
|
| Free Cash Flow | - | -5.7 | -6.5 | -9.83 | -43.52 | -9.31 | Upgrade
|
| Free Cash Flow Per Share | - | -0.30 | -0.34 | -0.51 | -2.28 | -0.49 | Upgrade
|
| Gross Margin | - | 62.49% | 70.12% | - | -85.02% | - | Upgrade
|
| Operating Margin | -4490661.76% | -1807.60% | -908.98% | -4591.68% | -3623.19% | - | Upgrade
|
| Profit Margin | -4608821.08% | -1881.58% | -887.23% | -4508.10% | -432.36% | - | Upgrade
|
| Free Cash Flow Margin | - | -1194.34% | -694.10% | -4218.27% | -13289.06% | - | Upgrade
|
| EBITDA | -7.69 | -7.16 | -7.05 | -9.24 | -6.73 | -41.3 | Upgrade
|
| D&A For EBITDA | 1.47 | 1.47 | 1.47 | 1.46 | 5.14 | 5.56 | Upgrade
|
| EBIT | -9.16 | -8.63 | -8.51 | -10.7 | -11.86 | -46.86 | Upgrade
|
| Revenue as Reported | 0 | 0.48 | 0.94 | 0.23 | 2.91 | 1.95 | Upgrade
|
| Advertising Expenses | - | 0.04 | 0.04 | 0.08 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.